NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gut-Brain Axis Therapeutics, Inc.

Gut-Brain Axis Therapeutics, Inc.

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://gutbrainaxistherapeutics.com/

Last Round

Series A

Nov 6, 2025

Total Funding Raised

$6M

Company Overview

Gut-Brain Axis Therapeutics, Inc. is a biotechnology company that develops microbiota transplant therapies aimed at treating gastrointestinal disorders and symptoms associated with autism and Pitt-Hopkins syndrome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gut-brain axismicrobiota transplant therapyMTTbiotechnologydrug developmentpreclinical researchmicrobiome therapeuticsneurological disordersgastrointestinal conditionsdrug discoverybiotech startupclinical pipelinepharmacological agentsbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gut-Brain Axis Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Gut-Brain Axis Therapeutics, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gut-Brain Axis Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 6, 2025
SeedDec 20, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Sophie Durand

Chief Financial Officer

Executive Team

Gut-Brain Axis Therapeutics, Inc. Investors

Notable investors and investment history

Gut-Brain Axis Therapeutics, Inc. investors
InvestorRounds
HealthTech CapitalSeed
View all Investors

Gut-Brain Axis Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gut-Brain Axis Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gut-Brain Axis Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range7
Year Founded2022
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.